Qualification of Drivers; Exemption Applications; Diabetes Mellitus, 73946-73948 [2014-29152]
Download as PDF
73946
Federal Register / Vol. 79, No. 239 / Friday, December 12, 2014 / Notices
which such actions were taken, are
described in the combined Record of
Decision (ROD) and Final
Environmental Impacts Statement
SUMMARY: This notice announces actions (FEIS) approved on November 25, 2014,
taken by the FHWA and other Federal
and in other documents in the FHWA
Agencies that are final within the
administrative record. The combined
meaning of 23 U.S.C. 139(l)(1). The
ROD and FEIS was prepared pursuant to
actions relate to the Interstate 43 (I–43)
the Moving Ahead for Progress in the
Freeway Improvement Project in
21st Century Act (MAP–21), Public Law
Milwaukee and Ozaukee Counties,
112–141, § 1319, 126 Stat. 405 (2012).
Wisconsin. Those actions grant
The combined ROD and FEIS, and
approvals for the project.
other documents in the administrative
DATES: By this notice, the FHWA is
record are available by contacting
advising the public of final agency
FHWA at the address provided above.
actions subject to 23 U.S.C. 139(l)(1).
The combined ROD and FEIS can be
Claims seeking judicial review of the
downloaded from the project Web site at
Federal agency actions on the highway
https://www.dot.wisconsin.gov/projects/
project will be barred unless the claim
seregion/43/index.htm; or viewed at
is filed on or before May 11, 2015. If the offices of local governments and
Federal law that authorizes judicial
transportation agencies in the project
review of a claim provides a time period area; or at the following public libraries:
of less than 150 days for filing such
Whitefish Bay Public Library (5420 N.
claim, then that shorter time period still Marlborough Dr., Whitefish Bay, WI),
applies.
North Shore Public Library (6800 N.
Port Washington Rd., Glendale, WI),
FOR FURTHER INFORMATION CONTACT:
Frank L. Weyenberg Library (11345 N.
George Poirier, Division Administrator,
Cedarburg Rd., Mequon, WI), and U.S.S.
FHWA, 525 Junction Road, Suite 8000,
Liberty Memorial Public Library (1620
Madison, Wisconsin 53717; telephone:
11th Ave., Grafton, WI).
(608) 829–7500. The FHWA Wisconsin
This notice applies to all Federal
Division’s normal office hours are 7 a.m.
agency decisions as of the issuance date
to 4 p.m. central time.
of this notice and all laws under which
SUPPLEMENTARY INFORMATION: Notice is
such actions were taken, including but
hereby given that FHWA and other
Federal agencies have taken final agency not limited to:
1. General: National Environmental
actions subject to 23 U.S.C. 139(l)(1) by
Policy Act (NEPA) [42 U.S.C. 4321–
issuing approvals for the following
4351], Federal-Aid Highway Act [23
highway project: I–43 Freeway
Improvement Project from Silver Spring U.S.C. 109, 23 U.S.C. 128, and 23 U.S.C.
139].
Drive to Wisconsin 60 (WIS 60) in
2. Air: Clean Air Act [42 U.S.C. 7401–
Milwaukee and Ozaukee Counties,
Wisconsin. The purpose of the project is 7671(q) and 23 U.S.C. 109(j)].
3. Land: Section 4(f) of the
to address emerging pavement and
Department of Transportation Act of
structural needs, safety issues, and
1966 [23 U.S.C. 138 and 49 U.S.C. 303].
design deficiencies while identifying
4. Wildlife: Endangered Species Act
methods to accommodate existing and
[16 U.S.C. 1531–1544 and Section
projected future traffic volumes. The
project also strives to minimize impacts 1536], Fish and Wildlife Coordination
Act [16 U.S.C. 661–667(d)], Migratory
to the natural, cultural and built
Bird Treaty Act [16 U.S.C. 703–712].
environment to the extent feasible and
5. Historic and Cultural Resources:
practicable. The project will widen the
existing I–43 four-lane divided highway Section 106 of the National Historic
Preservation Act of 1966, as amended
to a six-lane divided highway for
[16 U.S.C. 470(f) et seq.].
approximately 14 miles from Silver
6. Social and Economic: Civil Rights
Spring Drive to WIS 60. The scope of
the proposed action includes rebuilding Act of 1964 [42 U.S.C. 2000(d)–
2000(d)(1)], Uniform Relocation
the mainline roadway, bridges, and
Assistance and Real Property
interchanges; replacing the existing
partial interchange at County Line Road Acquisition Act of 1970 [42 U.S.C. 4601
et seq. as amended by the Uniform
with a full-access interchange;
Relocation Act Amendments of 1987
constructing a new interchange at
[Pub. L. 100–17].
Highland Road; reconstructing local
7. Wetlands and Water Resources:
streets affected by the freeway
Clean Water Act (Section 404, Section
reconstruction; and enhancing the
401, and Section 319) [33 U.S.C. 1251–
aesthetic appearance of the
1376].
reconstructed freeway.
8. Hazardous Materials:
The actions by the Federal agencies
Comprehensive Environmental
on this project, and the laws under
Notice of limitation on claims
for judicial review of actions by FHWA
and other federal agencies.
mstockstill on DSK4VPTVN1PROD with NOTICES
ACTION:
VerDate Sep<11>2014
16:57 Dec 11, 2014
Jkt 235001
PO 00000
Frm 00068
Fmt 4703
Sfmt 4703
Response, Compensation, and Liability
Act [42 U.S.C. 9601–9675].
9. Executive Orders: E.O. 11990
Protection of Wetlands, E.O. 11988
Floodplain Management, E.O. 12898
Federal Actions to Address
Environmental Justice in Minority
Populations and Low Income
Populations, E.O. 13175 Consultation
and Coordination with Indian Tribal
Governments, E.O. 11514 Protection and
Enhancement of Environmental Quality,
E.O. 13112 Invasive Species.
(Catalog of Federal Domestic Assistance
Program Number 20.205, Highway Planning
and Construction. The regulations
implementing Executive Order 12372
regarding intergovernmental consultation on
Federal programs and activities apply to this
program.)
Authority: 23 U.S.C. 139(l)(1), as amended
by Moving Ahead for Progress in the 21st
Century Act (MAP–21), Public Law 112–141,
§ 1308, 126 Stat. 405 (2012).
Issued on: December 2, 2014.
George R. Poirier,
Division Administrator, Madison, Wisconsin.
[FR Doc. 2014–28922 Filed 12–11–14; 8:45 am]
BILLING CODE 4910–RY–P
DEPARTMENT OF TRANSPORTATION
Federal Motor Carrier Safety
Administration
[FMCSA Docket No. FMCSA–2014–0021]
Qualification of Drivers; Exemption
Applications; Diabetes Mellitus
Federal Motor Carrier Safety
Administration (FMCSA), DOT.
ACTION: Notice of final disposition.
AGENCY:
FMCSA confirms its decision
to exempt 78 individuals from its rule
prohibiting persons with insulin-treated
diabetes mellitus (ITDM) from operating
commercial motor vehicles (CMVs) in
interstate commerce. The exemptions
enable these individuals to operate
CMVs in interstate commerce.
DATES: The exemptions were effective
on October 21, 2014. The exemptions
expire on October 21, 2016.
FOR FURTHER INFORMATION CONTACT:
Elaine M. Papp, R.N., Chief, Medical
Programs Division, (202) 366–4001,
fmcsamedical@dot.gov, FMCSA, Room
W64–224, Department of
Transportation, 1200 New Jersey
Avenue SE., Washington, DC 20590–
0001. Office hours are from 8:30 a.m. to
5 p.m., Monday through Friday, except
Federal holidays.
SUPPLEMENTARY INFORMATION:
SUMMARY:
E:\FR\FM\12DEN1.SGM
12DEN1
Federal Register / Vol. 79, No. 239 / Friday, December 12, 2014 / Notices
I. Electronic Access
You may see all the comments online
through the Federal Document
Management System (FDMS) at: https://
www.regulations.gov.
Docket: For access to the docket to
read background documents or
comments, go to https://
www.regulations.gov and/or Room
W12–140 on the ground level of the
West Building, 1200 New Jersey Avenue
SE., Washington, DC, between 9 a.m.
and 5 p.m., Monday through Friday,
except Federal holidays.
Privacy Act: Anyone may search the
electronic form of all comments
received into any of DOT’s dockets by
the name of the individual submitting
the comment (or of the person signing
the comment, if submitted on behalf of
an association, business, labor union, or
other entity). You may review DOT’s
Privacy Act Statement for the Federal
Docket Management System (FDMS)
published in the Federal Register on
January 17, 2008 (73 FR 3316).
II. Background
On September 18, 2014, FMCSA
published a notice of receipt of Federal
diabetes exemption applications from
78 individuals and requested comments
from the public (79 FR 56107). The
public comment period closed on
October 20, 2014, and four comments
were received.
FMCSA has evaluated the eligibility
of the 78 applicants and determined that
granting the exemptions to these
individuals would achieve a level of
safety equivalent to or greater than the
level that would be achieved by
complying with the current regulation
49 CFR 391.41(b)(3).
mstockstill on DSK4VPTVN1PROD with NOTICES
III. Diabetes Mellitus and Driving
Experience of the Applicants
The Agency established the current
requirement for diabetes in 1970
because several risk studies indicated
that drivers with diabetes had a higher
rate of crash involvement than the
general population. The diabetes rule
provides that ‘‘A person is physically
qualified to drive a commercial motor
vehicle if that person has no established
medical history or clinical diagnosis of
diabetes mellitus currently requiring
insulin for control’’ (49 CFR
391.41(b)(3)).
FMCSA established its diabetes
exemption program, based on the
Agency’s July 2000 study entitled ‘‘A
Report to Congress on the Feasibility of
a Program to Qualify Individuals with
Insulin-Treated Diabetes Mellitus to
Operate in Interstate Commerce as
Directed by the Transportation Act for
VerDate Sep<11>2014
16:57 Dec 11, 2014
Jkt 235001
the 21st Century.’’ The report concluded
that a safe and practicable protocol to
allow some drivers with ITDM to
operate CMVs is feasible. The
September 3, 2003 (68 FR 52441),
Federal Register notice in conjunction
with the November 8, 2005 (70 FR
67777), Federal Register notice provides
the current protocol for allowing such
drivers to operate CMVs in interstate
commerce.
These 78 applicants have had ITDM
over a range of 1 to 48 years. These
applicants report no severe
hypoglycemic reactions resulting in loss
of consciousness or seizure, requiring
the assistance of another person, or
resulting in impaired cognitive function
that occurred without warning
symptoms, in the past 12 months and no
recurrent (2 or more) severe
hypoglycemic episodes in the past 5
years. In each case, an endocrinologist
verified that the driver has
demonstrated a willingness to properly
monitor and manage his/her diabetes
mellitus, received education related to
diabetes management, and is on a stable
insulin regimen. These drivers report no
other disqualifying conditions,
including diabetes-related
complications. Each meets the vision
requirement at 49 CFR 391.41(b)(10).
The qualifications and medical
condition of each applicant were stated
and discussed in detail in the
September 18, 2014, Federal Register
notice and they will not be repeated in
this notice.
IV. Discussion of Comments
FMCSA received four comments in
this proceeding. The comments are
discussed below.
Gregory Witt believes that drivers
should be granted an exemption if a
doctor is satisfied that their diabetes is
adequately controlled by medication.
Ashley Warren opposes the ruling in
FMCSA–2014–0021 because she does
not believe drivers are required to
receive medical examinations more than
every two years. As described in
‘‘Section VI. Conditions and
Requirements’’ in this document, all
drivers must submit quarterly and
annual evaluations from a board-eligible
or board-certified endocrinologist each
year throughout the duration of the
exemption, as well as annual
evaluations from an optometrist or
ophthalmologist (if the driver has
diabetic retinopathy, the evaluation
must be completed by an
ophthalmologist). In addition, exempted
drivers are required to receive an annual
DOT physical examination to ensure
that they meet all other medical
standards not related to ITDM.
PO 00000
Frm 00069
Fmt 4703
Sfmt 4703
73947
Daniel Adams submitted two
comments addressing Ashley Warren’s
comment, explaining the many
evaluations drivers are required to
submit throughout the duration of their
exemption period.
V. Basis for Exemption Determination
Under 49 U.S.C. 31136(e) and 31315,
FMCSA may grant an exemption from
the diabetes requirement in 49 CFR
391.41(b)(3) if the exemption is likely to
achieve an equivalent or greater level of
safety than would be achieved without
the exemption. The exemption allows
the applicants to operate CMVs in
interstate commerce.
To evaluate the effect of these
exemptions on safety, FMCSA
considered medical reports about the
applicants’ ITDM and vision, and
reviewed the treating endocrinologists’
medical opinion related to the ability of
the driver to safely operate a CMV while
using insulin.
Consequently, FMCSA finds that in
each case exempting these applicants
from the diabetes requirement in 49 CFR
391.41(b)(3) is likely to achieve a level
of safety equal to that existing without
the exemption.
VI. Conditions and Requirements
The terms and conditions of the
exemption will be provided to the
applicants in the exemption document
and they include the following: (1) That
each individual submit a quarterly
monitoring checklist completed by the
treating endocrinologist as well as an
annual checklist with a comprehensive
medical evaluation; (2) that each
individual reports within 2 business
days of occurrence, all episodes of
severe hypoglycemia, significant
complications, or inability to manage
diabetes; also, any involvement in an
accident or any other adverse event in
a CMV or personal vehicle, whether or
not it is related to an episode of
hypoglycemia; (3) that each individual
provide a copy of the ophthalmologist’s
or optometrist’s report to the medical
examiner at the time of the annual
medical examination; and (4) that each
individual provide a copy of the annual
medical certification to the employer for
retention in the driver’s qualification
file, or keep a copy in his/her driver’s
qualification file if he/she is selfemployed. The driver must also have a
copy of the certification when driving,
for presentation to a duly authorized
Federal, State, or local enforcement
official.
VII. Conclusion
Based upon its evaluation of the 78
exemption applications, FMCSA
E:\FR\FM\12DEN1.SGM
12DEN1
mstockstill on DSK4VPTVN1PROD with NOTICES
73948
Federal Register / Vol. 79, No. 239 / Friday, December 12, 2014 / Notices
exempts the following drivers from the
diabetes requirement in 49 CFR
391.41(b)(10), subject to the
requirements cited above 949 CFR
391.64(b)):
Daniel S. Adams (ME)
Michael L. Agnitsch (NE)
Shaun M. Aguayo (TX)
Earl W. Avery (TN)
Douglas W. Baker, Sr. (VA)
Michael A. Baker (CT)
Douglas E. Barron (SC)
Pablo H. Bilbao La Vieja Pozo (RI)
Todd D. Bloomfield (WA)
Sylvester G. Clements, Jr. (WI)
Fred W. Click (IN)
Kenneth M. Coco (TX)
Christopher R. Cook (NY)
Wygila M. Corliss (NM)
Timothy J. Cornish (OH)
Joshua D. Cresswell (NH)
Evan R. Dieken (MN)
Greg B. Duck (TX)
Arthur J. Dunn (PA)
Richard A. Durr (IL)
Daniel R. Eloff (OH)
Thomas O. Everett (WA)
Victor J. Flowers (CA)
Brian K. Forrest (PA)
David S. Fortune (VA)
Michael S. Frederick (NJ)
Peter E. Ganss (KS)
David E. Gates (MA)
Timothy L. Grant (NC)
James T. Heck (MN)
Rodney J. Hendricks (ID)
Marcus T. Herring (CA)
Charles R. Hoit (MO)
Jason L. Hubbard (MD)
Andy L. Hughes (IL)
Jammie L. Hughes (OH)
Charles J. Hurley (MN)
Rodney L. Johnson (OR)
Frederick B. Jones (TX)
Tito D. Jones (GA)
Scott M. Klain (OR)
Jeffrey P. Kloeckl (SD)
John J. Kress (AZ)
Russell A. Krogstad (MN)
John B. Lebherz (TX)
Alan S. Lewis (NM)
William M. Linskey (MA)
Jason D. Lowder (OH)
Arnold V. Magaoay (HI)
Norman C. Mallett (AR)
Patrick Marcantuono (NJ)
Daniel E. McDonald (MN)
William F. McQueen, Jr. (MO)
Kenneth M. Miller (ID)
William F. Mitchell (CT)
Donald L. Mitzel (PA)
Gino P. Monterio (WI)
Matthew K. Morrison (UT)
Gary R. Nelson (MN)
Edward L. Norfleet (AL)
Kyle R. Perry (PA)
Michael L. Plinski (WA)
Scott A. Porter (WA)
VerDate Sep<11>2014
16:57 Dec 11, 2014
Jkt 235001
James A. Rambo (VA)
Rondo L. Rininger (IN)
Richard D. Sandison (ND)
Calvin R. Smith (IL)
Wesley J. Summerville (PA)
Jeffrey S. Thomas (PA)
Stephen M. Thompson (GA)
Randy L. Triplett (OH)
John E. Trygstad (SD)
Jared M. Wabeke (MI)
Steven R. Weir (MA)
Donald D. Willard (IA)
Gary W. Wozniak (NE)
Steven L. Yokom (ID)
Daniel R. Zuriff (MN)
In accordance with 49 U.S.C. 31136(e)
and 31315 each exemption is valid for
two years unless revoked earlier by
FMCSA. The exemption will be revoked
if the following occurs: (1) The person
fails to comply with the terms and
conditions of the exemption; (2) the
exemption has resulted in a lower level
of safety than was maintained before it
was granted; or (3) continuation of the
exemption would not be consistent with
the goals and objectives of 49 U.S.C.
31136(e) and 31315. If the exemption is
still effective at the end of the 2-year
period, the person may apply to FMCSA
for a renewal under procedures in effect
at that time.
Issued on: December 5, 2014.
Larry W. Minor,
Associate Administrator for Policy.
[FR Doc. 2014–29152 Filed 12–11–14; 8:45 am]
BILLING CODE 4910–EX–P
DEPARTMENT OF TRANSPORTATION
Federal Railroad Administration
[Docket No. FRA–2014–0115]
Notice of Application for Approval of
Discontinuance or Modification of a
Railroad Signal System
In accordance with Part 235 of Title
49 Code of Federal Regulations (CFR)
and 49 U.S.C. 20502(a), this document
provides the public notice that by a
document dated October 22, 2014,
Norfolk Southern Corporation (NS) has
petitioned the Federal Railroad
Administration (FRA) seeking approval
for the discontinuance or modification
of a signal system. FRA assigned the
petition Docket Number FRA–2014–
0115.
Applicant: Norfolk Southern
Corporation, Mr. Brian L. Sykes, Chief
Engineer C&S Engineering, 1200
Peachtree Street NE., Atlanta, GA
30309.
NS seeks approval of the proposed
discontinuance of a traffic control
system (TCS) on the Winding Gulf
PO 00000
Frm 00070
Fmt 4703
Sfmt 4703
Branch between Horsepen, Milepost
(MP) WG 6.5 and Tams, MP WG 12.1,
near Amigo, WV.
The reason given for the proposed
changes is that the TCS is no longer
desirable or needed to handle current
train operations. The TCS will be
discontinued and replaced with NS
Rule 171 for track authority operation.
CP Horsepen will be renewed, and fixed
approach signals will be installed, in
approach to the start of TCS territory.
A copy of the petition, as well as any
written communications concerning the
petition, is available for review online at
www.regulations.gov and in person at
the U.S. Department of Transportation’s
(DOT) Docket Operations Facility, 1200
New Jersey Avenue SE., W12–140,
Washington, DC 20590. The Docket
Operations Facility is open from 9 a.m.
to 5 p.m., Monday through Friday,
except Federal Holidays.
Interested parties are invited to
participate in these proceedings by
submitting written views, data, or
comments. FRA does not anticipate
scheduling a public hearing in
connection with these proceedings since
the facts do not appear to warrant a
hearing. If any interested party desires
an opportunity for oral comment, they
should notify FRA, in writing, before
the end of the comment period and
specify the basis for their request.
All communications concerning these
proceedings should identify the
appropriate docket number and may be
submitted by any of the following
methods:
• Web site: https://
www.regulations.gov. Follow the online
instructions for submitting comments.
• Fax: 202–493–2251.
• Mail: Docket Operations Facility,
U.S. Department of Transportation, 1200
New Jersey Avenue SE., W12–140,
Washington, DC 20590.
• Hand Delivery: 1200 New Jersey
Avenue SE., Room W12–140,
Washington, DC 20590, between 9 a.m.
and 5 p.m., Monday through Friday,
except Federal Holidays.
Communications received by January
26, 2015 will be considered by FRA
before final action is taken. Comments
received after that date will be
considered as far as practicable.
Anyone is able to search the
electronic form of any written
communications and comments
received into any of our dockets by the
name of the individual submitting the
comment (or signing the document, if
submitted on behalf of an association,
business, labor union, etc.). In
accordance with 5 U.S.C. 553(c), DOT
solicits comments from the public to
E:\FR\FM\12DEN1.SGM
12DEN1
Agencies
[Federal Register Volume 79, Number 239 (Friday, December 12, 2014)]
[Notices]
[Pages 73946-73948]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-29152]
-----------------------------------------------------------------------
DEPARTMENT OF TRANSPORTATION
Federal Motor Carrier Safety Administration
[FMCSA Docket No. FMCSA-2014-0021]
Qualification of Drivers; Exemption Applications; Diabetes
Mellitus
AGENCY: Federal Motor Carrier Safety Administration (FMCSA), DOT.
ACTION: Notice of final disposition.
-----------------------------------------------------------------------
SUMMARY: FMCSA confirms its decision to exempt 78 individuals from its
rule prohibiting persons with insulin-treated diabetes mellitus (ITDM)
from operating commercial motor vehicles (CMVs) in interstate commerce.
The exemptions enable these individuals to operate CMVs in interstate
commerce.
DATES: The exemptions were effective on October 21, 2014. The
exemptions expire on October 21, 2016.
FOR FURTHER INFORMATION CONTACT: Elaine M. Papp, R.N., Chief, Medical
Programs Division, (202) 366-4001, fmcsamedical@dot.gov, FMCSA, Room
W64-224, Department of Transportation, 1200 New Jersey Avenue SE.,
Washington, DC 20590-0001. Office hours are from 8:30 a.m. to 5 p.m.,
Monday through Friday, except Federal holidays.
SUPPLEMENTARY INFORMATION:
[[Page 73947]]
I. Electronic Access
You may see all the comments online through the Federal Document
Management System (FDMS) at: https://www.regulations.gov.
Docket: For access to the docket to read background documents or
comments, go to https://www.regulations.gov and/or Room W12-140 on the
ground level of the West Building, 1200 New Jersey Avenue SE.,
Washington, DC, between 9 a.m. and 5 p.m., Monday through Friday,
except Federal holidays.
Privacy Act: Anyone may search the electronic form of all comments
received into any of DOT's dockets by the name of the individual
submitting the comment (or of the person signing the comment, if
submitted on behalf of an association, business, labor union, or other
entity). You may review DOT's Privacy Act Statement for the Federal
Docket Management System (FDMS) published in the Federal Register on
January 17, 2008 (73 FR 3316).
II. Background
On September 18, 2014, FMCSA published a notice of receipt of
Federal diabetes exemption applications from 78 individuals and
requested comments from the public (79 FR 56107). The public comment
period closed on October 20, 2014, and four comments were received.
FMCSA has evaluated the eligibility of the 78 applicants and
determined that granting the exemptions to these individuals would
achieve a level of safety equivalent to or greater than the level that
would be achieved by complying with the current regulation 49 CFR
391.41(b)(3).
III. Diabetes Mellitus and Driving Experience of the Applicants
The Agency established the current requirement for diabetes in 1970
because several risk studies indicated that drivers with diabetes had a
higher rate of crash involvement than the general population. The
diabetes rule provides that ``A person is physically qualified to drive
a commercial motor vehicle if that person has no established medical
history or clinical diagnosis of diabetes mellitus currently requiring
insulin for control'' (49 CFR 391.41(b)(3)).
FMCSA established its diabetes exemption program, based on the
Agency's July 2000 study entitled ``A Report to Congress on the
Feasibility of a Program to Qualify Individuals with Insulin-Treated
Diabetes Mellitus to Operate in Interstate Commerce as Directed by the
Transportation Act for the 21st Century.'' The report concluded that a
safe and practicable protocol to allow some drivers with ITDM to
operate CMVs is feasible. The September 3, 2003 (68 FR 52441), Federal
Register notice in conjunction with the November 8, 2005 (70 FR 67777),
Federal Register notice provides the current protocol for allowing such
drivers to operate CMVs in interstate commerce.
These 78 applicants have had ITDM over a range of 1 to 48 years.
These applicants report no severe hypoglycemic reactions resulting in
loss of consciousness or seizure, requiring the assistance of another
person, or resulting in impaired cognitive function that occurred
without warning symptoms, in the past 12 months and no recurrent (2 or
more) severe hypoglycemic episodes in the past 5 years. In each case,
an endocrinologist verified that the driver has demonstrated a
willingness to properly monitor and manage his/her diabetes mellitus,
received education related to diabetes management, and is on a stable
insulin regimen. These drivers report no other disqualifying
conditions, including diabetes-related complications. Each meets the
vision requirement at 49 CFR 391.41(b)(10).
The qualifications and medical condition of each applicant were
stated and discussed in detail in the September 18, 2014, Federal
Register notice and they will not be repeated in this notice.
IV. Discussion of Comments
FMCSA received four comments in this proceeding. The comments are
discussed below.
Gregory Witt believes that drivers should be granted an exemption
if a doctor is satisfied that their diabetes is adequately controlled
by medication.
Ashley Warren opposes the ruling in FMCSA-2014-0021 because she
does not believe drivers are required to receive medical examinations
more than every two years. As described in ``Section VI. Conditions and
Requirements'' in this document, all drivers must submit quarterly and
annual evaluations from a board-eligible or board-certified
endocrinologist each year throughout the duration of the exemption, as
well as annual evaluations from an optometrist or ophthalmologist (if
the driver has diabetic retinopathy, the evaluation must be completed
by an ophthalmologist). In addition, exempted drivers are required to
receive an annual DOT physical examination to ensure that they meet all
other medical standards not related to ITDM.
Daniel Adams submitted two comments addressing Ashley Warren's
comment, explaining the many evaluations drivers are required to submit
throughout the duration of their exemption period.
V. Basis for Exemption Determination
Under 49 U.S.C. 31136(e) and 31315, FMCSA may grant an exemption
from the diabetes requirement in 49 CFR 391.41(b)(3) if the exemption
is likely to achieve an equivalent or greater level of safety than
would be achieved without the exemption. The exemption allows the
applicants to operate CMVs in interstate commerce.
To evaluate the effect of these exemptions on safety, FMCSA
considered medical reports about the applicants' ITDM and vision, and
reviewed the treating endocrinologists' medical opinion related to the
ability of the driver to safely operate a CMV while using insulin.
Consequently, FMCSA finds that in each case exempting these
applicants from the diabetes requirement in 49 CFR 391.41(b)(3) is
likely to achieve a level of safety equal to that existing without the
exemption.
VI. Conditions and Requirements
The terms and conditions of the exemption will be provided to the
applicants in the exemption document and they include the following:
(1) That each individual submit a quarterly monitoring checklist
completed by the treating endocrinologist as well as an annual
checklist with a comprehensive medical evaluation; (2) that each
individual reports within 2 business days of occurrence, all episodes
of severe hypoglycemia, significant complications, or inability to
manage diabetes; also, any involvement in an accident or any other
adverse event in a CMV or personal vehicle, whether or not it is
related to an episode of hypoglycemia; (3) that each individual provide
a copy of the ophthalmologist's or optometrist's report to the medical
examiner at the time of the annual medical examination; and (4) that
each individual provide a copy of the annual medical certification to
the employer for retention in the driver's qualification file, or keep
a copy in his/her driver's qualification file if he/she is self-
employed. The driver must also have a copy of the certification when
driving, for presentation to a duly authorized Federal, State, or local
enforcement official.
VII. Conclusion
Based upon its evaluation of the 78 exemption applications, FMCSA
[[Page 73948]]
exempts the following drivers from the diabetes requirement in 49 CFR
391.41(b)(10), subject to the requirements cited above 949 CFR
391.64(b)):
Daniel S. Adams (ME)
Michael L. Agnitsch (NE)
Shaun M. Aguayo (TX)
Earl W. Avery (TN)
Douglas W. Baker, Sr. (VA)
Michael A. Baker (CT)
Douglas E. Barron (SC)
Pablo H. Bilbao La Vieja Pozo (RI)
Todd D. Bloomfield (WA)
Sylvester G. Clements, Jr. (WI)
Fred W. Click (IN)
Kenneth M. Coco (TX)
Christopher R. Cook (NY)
Wygila M. Corliss (NM)
Timothy J. Cornish (OH)
Joshua D. Cresswell (NH)
Evan R. Dieken (MN)
Greg B. Duck (TX)
Arthur J. Dunn (PA)
Richard A. Durr (IL)
Daniel R. Eloff (OH)
Thomas O. Everett (WA)
Victor J. Flowers (CA)
Brian K. Forrest (PA)
David S. Fortune (VA)
Michael S. Frederick (NJ)
Peter E. Ganss (KS)
David E. Gates (MA)
Timothy L. Grant (NC)
James T. Heck (MN)
Rodney J. Hendricks (ID)
Marcus T. Herring (CA)
Charles R. Hoit (MO)
Jason L. Hubbard (MD)
Andy L. Hughes (IL)
Jammie L. Hughes (OH)
Charles J. Hurley (MN)
Rodney L. Johnson (OR)
Frederick B. Jones (TX)
Tito D. Jones (GA)
Scott M. Klain (OR)
Jeffrey P. Kloeckl (SD)
John J. Kress (AZ)
Russell A. Krogstad (MN)
John B. Lebherz (TX)
Alan S. Lewis (NM)
William M. Linskey (MA)
Jason D. Lowder (OH)
Arnold V. Magaoay (HI)
Norman C. Mallett (AR)
Patrick Marcantuono (NJ)
Daniel E. McDonald (MN)
William F. McQueen, Jr. (MO)
Kenneth M. Miller (ID)
William F. Mitchell (CT)
Donald L. Mitzel (PA)
Gino P. Monterio (WI)
Matthew K. Morrison (UT)
Gary R. Nelson (MN)
Edward L. Norfleet (AL)
Kyle R. Perry (PA)
Michael L. Plinski (WA)
Scott A. Porter (WA)
James A. Rambo (VA)
Rondo L. Rininger (IN)
Richard D. Sandison (ND)
Calvin R. Smith (IL)
Wesley J. Summerville (PA)
Jeffrey S. Thomas (PA)
Stephen M. Thompson (GA)
Randy L. Triplett (OH)
John E. Trygstad (SD)
Jared M. Wabeke (MI)
Steven R. Weir (MA)
Donald D. Willard (IA)
Gary W. Wozniak (NE)
Steven L. Yokom (ID)
Daniel R. Zuriff (MN)
In accordance with 49 U.S.C. 31136(e) and 31315 each exemption is
valid for two years unless revoked earlier by FMCSA. The exemption will
be revoked if the following occurs: (1) The person fails to comply with
the terms and conditions of the exemption; (2) the exemption has
resulted in a lower level of safety than was maintained before it was
granted; or (3) continuation of the exemption would not be consistent
with the goals and objectives of 49 U.S.C. 31136(e) and 31315. If the
exemption is still effective at the end of the 2-year period, the
person may apply to FMCSA for a renewal under procedures in effect at
that time.
Issued on: December 5, 2014.
Larry W. Minor,
Associate Administrator for Policy.
[FR Doc. 2014-29152 Filed 12-11-14; 8:45 am]
BILLING CODE 4910-EX-P